The Functional-765G→C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease

被引:13
作者
de Vries, Hilbert S. [1 ]
Morsche, Rene H. M. Te [1 ]
van Oijen, Martijn G. H. [1 ,3 ]
Nagtegaal, Iris D. [2 ]
Peters, Wilbert H. M. [1 ]
de Jong, Dirk J. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
关键词
INFLAMMATORY-BOWEL-DISEASE; CYCLOOXYGENASE; 2; MESSENGER-RNA; EXPRESSION; ASSOCIATION; COLITIS; CANCER; PREVALENCE; INHIBITORS; RELAPSE;
D O I
10.1371/journal.pone.0015011
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins. COX-2 is mainly induced at sites of inflammation in response to proinflammatory cytokines such as interleukin-1 alpha/beta, interferon-gamma and tumor necrosis factor-alpha produced by inflammatory cells. Aim: The aim of this study was to investigate the possible modulating effect of the functional COX-2 polymorphisms -1195 A -> G and -765G -> C on the risk for development of inflammatory bowel disease (IBD) in a Dutch population. Methods: Genomic DNA of 525 patients with Crohn's disease (CD), 211 patients with ulcerative colitis (UC) and 973 healthy controls was genotyped for the -1195 A -> G (rs689466) and -765G -> C (rs20417) polymorphisms. Distribution of genotypes in patients and controls were compared and genotype-phenotype interactions were investigated. Results: The genotype distribution of the -1195A -> G polymorphism was not different between the patients with CD or UC and the control group. The -765GC genotype was more prevalent in CD patients compared to controls with an OR of 1.33 (95% CI 1.04-1.69, p < 0.05). The -765GC and -765CC genotype carriers showed a tendency to be less frequent in patients with CD compared to controls, with ORs of 0.78 (95% CI: 0.61-1.00) and 0.49 (95% CI 0.22-1.08), respectively. Combining homozygous and heterozygous patients with the -765C allele showed a reduced risk for developing CD, with an OR of 0.75 (95% CI: 0.59-0.96). In the context of this, the G(-1195)G(-765)/A(-1195)C(-765) diplotype was significantly less common in patients with CD compared to controls, with an OR of 0.62 (95% CI: 0.39-0.98). For UC however, such an effect was not observed. No correlation was found between COX-2 diplotypes and clinical characteristics of IBD. Conclusions: The -765G -> C polymorphism was associated with a reduced risk for developing Crohn's disease in a Dutch population.
引用
收藏
页数:6
相关论文
共 40 条
[1]   The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia [J].
Agoff, SN ;
Brentnall, TA ;
Crispin, DA ;
Taylor, SL ;
Raaka, S ;
Haggitt, RC ;
Reed, MW ;
Afonina, IA ;
Rabinovitch, PS ;
Stevens, AC ;
Feng, ZD ;
Bronner, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03) :737-745
[2]  
ANDERSEN V, INFLAMM BOW IN PRESS
[3]   Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial [J].
Biancone, L ;
Tosti, C ;
Geremia, A ;
Fina, D ;
Petruzziello, C ;
Emerenziani, S ;
Pallone, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (07) :755-764
[4]   Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling [J].
Boniface, Katia ;
Bak-Jensen, Kristian S. ;
Li, Ying ;
Blumenschein, Wendy M. ;
McGeachy, Mandy J. ;
McClanahan, Terrill K. ;
McKenzie, Brent S. ;
Kastelein, Robert A. ;
Cua, Daniel J. ;
Malefyt, Rene de Waal .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (03) :535-548
[5]   Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper [J].
Carty, E ;
De Brabander, M ;
Feakins, RM ;
Rampton, DS .
GUT, 2000, 46 (04) :487-492
[6]  
Casparie M, 2007, CELL ONCOL, V29, P19
[7]   Influence of Cyclooxygenase-2 (COX-2) Gene Promoter Polymorphism-765 on Graft Loss After Renal Transplantation [J].
Courivaud, C. ;
Bamoulid, J. ;
Loupy, A. ;
Deschamps, M. ;
Ferrand, C. ;
Le Corre, D. ;
Tiberghien, P. ;
Chalopin, J. -M. ;
Legendre, C. ;
Thervet, E. ;
Saas, P. ;
Ducloux, D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (12) :2752-2757
[8]   A haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease [J].
Cox, David G. ;
Crusius, J. Bart A. ;
Peeters, Petra H. M. ;
Bueno-de-Mesquita, H. Bas ;
Pena, A. Salvador ;
Canzian, Federico .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (38) :6003-6008
[9]   Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions [J].
Fornai, Matteo ;
Antonioli, Luca ;
Colucci, Rocchina ;
Bernardini, Nunzia ;
Ghisu, Narcisa ;
Tuccori, Marco ;
De Giorgio, Roberto ;
Del Tacca, Mario ;
Blandizzi, Corrado .
PHARMACOLOGY & THERAPEUTICS, 2010, 125 (01) :62-78
[10]   A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998 [J].
Gasche, C ;
Scholmerich, J ;
Brynskov, J ;
D'Haens, G ;
Hanauer, SB ;
Irvine, EJ ;
Jewell, DP ;
Rachmilewitz, D ;
Sachar, DB ;
Sandborn, WJ ;
Sutherland, LR .
INFLAMMATORY BOWEL DISEASES, 2000, 6 (01) :8-15